* For medical professionals reading only
Come and cast the breast cancer 2022 hot words, grasp the new trend of breast diagnosis and treatment
At the end of 2021, the Yangtze River Academic Breast Breast Alliance (YBCSG) released the first top ten "Academic Keywords of the Year" for breast cancer, showing the audience and readers the important achievements and cutting-edge trends in the field of breast cancer, which aroused widespread attention and heated discussion. (Reference reading: The Yangtze River Academic Breast Breast Alliance released the top ten "annual academic keywords" for breast cancer in 2021)
Now, it is the end of the year again, and the "annual academic keywords" selection for the new year has arrived as scheduled.
In the new year, the screening process and evaluation system of "annual academic keywords" have been optimized and improved. It not only covers relevant abstracts and reports from internationally renowned conferences such as the American Society of Clinical Oncology (ASCO), the European Society of Oncology (ESMO), and the San Antonio Breast Cancer Seminar (SABCS) in the past year, but also includes related paper reports from top journals such as the Lancet, Nature, New England Journal of Medicine, American Medical Association and the Annual of Oncology. On this basis, experts vote on the top 25 keywords, comprehensively summarize the results of various scoring to form the top ten "annual academic keywords". The
scoring rules are as follows (the specific details will be announced in the conference):
includes the literature published by foreign journals related to tumors with an impact factor of >10 points from January to November 2022, as well as oral reports of international conferences, poster discussions/mini orals, and posters in the keyword search range, and perform frequency calculations, and scores according to certain weights (each of journal and conference each account for 40%).
"Finnered Guest" Display:
In the past year, the epidemic has remained the focus of attention all over the world. Whether in academic conferences or in top journals, COVID-19 has been mentioned at the top.
Molecular typing of breast cancer is the basis of current breast cancer treatment strategies. HER2 positive, HER2 low expression, and triple-negative breast cancer have all been on the list, becoming a high-frequency hot word in clinical research. Targeted drugs such as
CDK4/6 inhibitors, and antibody drug conjugates such as T-DXd (DS-8201) are still very popular in the field of breast cancer. The results of the
DESTINY-Breast series of research were released, changing the treatment pattern of breast cancer.
Immune therapy (immune therapy) has developed rapidly in the field of breast cancer and has become a highly anticipated new force.
Pathological complete remission of efficacy evaluation indicators such as (pCR) and quality of life (QoL/PRO) , providing a more comprehensive perspective for the overall patient's condition, drug efficacy and subsequent decision-making.
…
In your mind, which are the academic keywords of the 2022 year in the field of breast cancer? Send your precious vote!
According to the above optimized scoring rules, the weight is 80%, and the experts vote 20%. We will sort out the top ten hot words for breast cancer in 2022 in order, and will be announced and interpreted at the 2022 year-end conference of the Yangtze River Academic Breast Band Alliance (YBCSG). Stay tuned.
*The medical community strives to ensure the accuracy and reliability of the published content when it is approved, but does not make any commitments and guarantees regarding the timeliness of the published content, as well as the accuracy and completeness of the cited materials (if any), and does not assume any responsibility arising from such content being outdated, the possible inaccuracy or incompleteness of the cited materials. Please check separately when using this or using it as the basis for decision-making.
